z-logo
open-access-imgOpen Access
Transcriptional Read-Through Induction Treatment Trial in Intestinal Failure Induced by anEpCAMNonsense Mutation
Author(s) -
Mamata Sivagnanam,
James L. Mueller,
Réka Szigeti,
G. S. Gopalakrishna,
Richárd Kellermayer
Publication year - 2012
Publication title -
case reports in medicine
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.2
H-Index - 20
eISSN - 1687-9627
pISSN - 1687-9635
DOI - 10.1155/2012/173195
Subject(s) - nonsense mutation , medicine , intestinal failure , epithelial cell adhesion molecule , mutation , nonsense , cancer research , nonsense mediated decay , cell adhesion molecule , gene , genetics , immunology , biology , parenteral nutrition , rna , missense mutation , rna splicing
Congenital tufting enteropathy (CTE) is a rare autosomal recessive diarrheal disorder where epithelial tufts can be present from the duodenum to the large intestine. CTE has been linked to mutations in the epithelial cell adhesion molecule gene ( EpCAM ) Sivagnanam et al. (2008). We recently reported the first case with a nonsense mutation in EpCAM Sivagnanam et al. (2010). Here, we explored the clinical and molecular effects of enterally administered gentamicin in this CTE patient. Altogether, our findings indicate that the therapy employed was insufficient to produce notable read-through induction of the EpCAM premature termination codon. This report highlights the utility of genetic testing not only in respect of diagnostics, prognostics, and family planning, but potential mutation-specific therapeutic considerations as well.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom